Literature DB >> 9649940

Molecular aspects of myocarditis.

N E Bowles1, J A Towbin.   

Abstract

The mechanisms of pathogenesis of myocarditis have remained elusive. Despite the demonstration a decade ago that persistent viral infection of the myocardium occurred in many patients, a clear description of the pathologic progression has not been forthcoming. Over the past year, a number of studies have added to the data defining the crucial roles of cytokine expression in the myocardium and the aberrant induction of apoptosis. Further, a mouse model of myocarditis resulting from the myocardial expression of tumor necrosis factor-alpha has been described. In addition, the identification of the common coxsackievirus B and adenovirus receptor has offered an explanation for the puzzling observation that these highly distinct virus types both cause cardiac disease. Finally, the near-eradication of endocardial fibroelastosis associated with persistent mumps virus infection by vaccination supports the notion that coxsackievirus B and adenovirus vaccines may help reduce the incidence of myocarditis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649940

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  14 in total

Review 1.  Myocarditis, pericarditis and other pericardial diseases.

Authors:  C M Oakley
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 2.  Role of RNA structure motifs in IRES-dependent translation initiation of the coxsackievirus B3: new insights for developing live-attenuated strains for vaccines and gene therapy.

Authors:  Amira Souii; Manel Ben M'hadheb-Gharbi; Jawhar Gharbi
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

3.  Calpain inhibition protects against virus-induced apoptotic myocardial injury.

Authors:  R L DeBiasi; C L Edelstein; B Sherry; K L Tyler
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

4.  Effects of the Sabin-like mutations in domain V of the internal ribosome entry segment on translational efficiency of the Coxsackievirus B3.

Authors:  Manel Ben M'hadheb-Gharbi; Jawhar Gharbi; Sylvie Paulous; Michèle Brocard; Anastasia Komaromva; Mahjoub Aouni; Katherine M Kean
Journal:  Mol Genet Genomics       Date:  2006-08-15       Impact factor: 3.291

Review 5.  Diagnosis and management of pediatric myocarditis.

Authors:  Desmond Bohn; Lee Benson
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva.

Authors:  A Henke; H Launhardt; K Klement; A Stelzner; R Zell; T Munder
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

7.  Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis.

Authors:  Guoli Chen; Xiaoyang Zhou; Stela Florea; Jiang Qian; Wenfeng Cai; Zhiguo Zhang; Guo-Chang Fan; John Lorenz; Roger J Hajjar; Evangelia G Kranias
Journal:  Basic Res Cardiol       Date:  2010-05-30       Impact factor: 17.165

8.  Necropsy diagnosis of myocarditis: a retrospective study using CD45RO immunohistochemistry.

Authors:  K M Feeley; J Harris; S K Suvarna
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

9.  Outcome Predictors for Pediatric Dilated Cardiomyopathy: A Systematic Review.

Authors:  Jorge A Alvarez; James D Wilkinson; Steven E Lipshultz
Journal:  Prog Pediatr Cardiol       Date:  2007-09-01

10.  Characterization of coxsackievirus B3-caused apoptosis under in vitro conditions.

Authors:  Ulrike Martin; Matthias Nestler; Thomas Munder; Roland Zell; Holger H Sigusch; Andreas Henke
Journal:  Med Microbiol Immunol       Date:  2003-09-12       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.